// App-Quantinova.ai

13003 2014 AHA : Efficacy of Cilostazol on Platelet Reactivity and Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention: Insights From a Meta-Analysis of Randomized Trials

Researchers

Presenter

  • Amita Singh

Principal Investigators

  • Frederick Feit

  • Sripal Bangalore

Medical Centers

  • New York Univ Sch of Med, New York, NY

  • Univ of Chicago, Chicago, IL

  • Virginia Commonwealth University, Mineral, VA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • cilostazol

  • Aspirin

  • Albyl-E

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim